Replies to post #114275 on Biotech Values

[DewDiligence]

The key takeaway from that piece is the tepid 5-7% growth rate that’s expected by BEC’s buyer. I’m hard-pressed to think of a company selling medical devices or disposables that is growing significantly faster.